|
AHNCI COE Breast Cancer Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Colon and Rectal Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Colon and Rectal Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Esophageal and Gastric Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Esophageal and Gastric Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Gynecologic Oncology Tumor Board 2024 |
|
01/01/2023 to 12/31/2024 |
|
AHNCI COE Gynecologic Oncology Tumor Board 2025 |
|
01/01/2023 to 12/31/2024 |
|
AHNCI COE Head and Neck Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Head and Neck Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Liver Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Liver Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Lung and Pleural Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Lung and Pleural Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Melanoma and Skin Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Melanoma and Skin Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Molecular, Metastatic and Rare Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Molecular, Metastatic and Rare Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Neurologic Oncology Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Neurologic Oncology Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Pancreas Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Pancreas Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Sarcoma Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Sarcoma Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
|
AHNCI COE Urologic Oncology Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Urologic Oncology Tumor Board 2025 |
|
01/01/2025 to 12/31/2025 |
Facebook
Twitter
LinkedIn
Forward